欢迎使用我们的服务！
限时优惠，立即购买享受折扣
24小时客服在线，随时为您服务
优质产品，值得信赖

印度仿制药专卖店
登录
顶 置

文章列表

Alvotech Broadens US Supply Footprint With Lotte Tie-Up

2026-10-09
Bristol Myers Squibb Deepens Commitment to Healthcare Professionals Through Champions in Care Movement

2026-10-09
BioJapan: Policy Changes Key To Rebuilding Japan’s Competitiveness

2026-10-09
BioJapan: Policy Changes Key To Rebuilding Japan’s Competitiveness

2026-10-09
U.S. Food and Drug Administration Approves Expanded Indication for Bristol Myers Squibb’s CAMZYOS® (mavacamten) for the Treatment of Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM) in Adults and Pediatric Patients*

2026-10-08
Aurobindo Receives FDA Approval for Brivaracetam Oral Solution, 10 mg/mL

2026-10-08
Advice on ‘end-of-year’ submission dates for type I variations in 2026

2026-10-08
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 28 September - 1 October

2026-10-08
First And Likely Only Entrant In US FDA’s Split Real-Time Review Pilot Is Arrowhead’s Plozasiran

2026-10-08
BridgeBio’s Infigratinib Poised To Join Achondroplasia Market Early Next Year

2026-10-07
Pipeline Watch: AbbVie and Mirum Score Back-to-Back FDA Wins With Juvmo and Atebrioz

2026-10-07
Biocon Malaysia Receives MHRA Approval for New Drug Product Fill Finish Unit for Insulins

2026-10-07